These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36830810)

  • 1. Data-Driven Phenotyping of Alzheimer's Disease under Epigenetic Conditions Using Partial Volume Correction of PET Studies and Manifold Learning.
    Campanioni S; González-Nóvoa JA; Busto L; Agís-Balboa RC; Veiga C
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of appropriate partial volume correction for PET quantification in Alzheimer's disease.
    Thomas BA; Erlandsson K; Modat M; Thurfjell L; Vandenberghe R; Ourselin S; Hutton BF
    Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1104-19. PubMed ID: 21336694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative
    Zhao Q; Liu M; Ha L; Zhou Y;
    Front Neurol; 2019; 10():486. PubMed ID: 31156534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Volume Correction Increases the Sensitivity of 18F-Florbetapir-Positron Emission Tomography for the Detection of Early Stage Amyloidosis.
    Teipel SJ; Dyrba M; Vergallo A; Lista S; Habert MO; Potier MC; Lamari F; Dubois B; Hampel H; Grothe MJ
    Front Aging Neurosci; 2021; 13():748198. PubMed ID: 35002673
    [No Abstract]   [Full Text] [Related]  

  • 6. Dissociation of Tau Deposits and Brain Atrophy in Early Alzheimer's Disease: A Combined Positron Emission Tomography/Magnetic Resonance Imaging Study.
    Shigemoto Y; Sone D; Imabayashi E; Maikusa N; Okamura N; Furumoto S; Kudo Y; Ogawa M; Takano H; Yokoi Y; Sakata M; Tsukamoto T; Kato K; Sato N; Matsuda H
    Front Aging Neurosci; 2018; 10():223. PubMed ID: 30072890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The feasibility of
    Sasaki K; Maikusa N; Imabayashi E; Yuasa T; Matsuda H
    Brain Behav; 2016 Oct; 6(10):e00532. PubMed ID: 27781145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging.
    Meltzer CC; Zubieta JK; Brandt J; Tune LE; Mayberg HS; Frost JJ
    Neurology; 1996 Aug; 47(2):454-61. PubMed ID: 8757020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET.
    Etminani K; Soliman A; Davidsson A; Chang JR; Martínez-Sanchis B; Byttner S; Camacho V; Bauckneht M; Stegeran R; Ressner M; Agudelo-Cifuentes M; Chincarini A; Brendel M; Rominger A; Bruffaerts R; Vandenberghe R; Kramberger MG; Trost M; Nicastro N; Frisoni GB; Lemstra AW; van Berckel BNM; Pilotto A; Padovani A; Morbelli S; Aarsland D; Nobili F; Garibotto V; Ochoa-Figueroa M
    Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):563-584. PubMed ID: 34328531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET.
    Brendel M; Delker A; Rötzer C; Böning G; Carlsen J; Cyran C; Mille E; Gildehaus FJ; Cumming P; Baumann K; Steiner H; Haass C; Herms J; Bartenstein P; Rominger A
    Neuroimage; 2014 Jan; 84():843-53. PubMed ID: 24055703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of tau deposition using
    Bullich S; Mueller A; De Santi S; Koglin N; Krause S; Kaplow J; Kanekiyo M; Roé-Vellvé N; Perrotin A; Jovalekic A; Scott D; Gee M; Stephens A; Irizarry M
    Alzheimers Res Ther; 2022 Jul; 14(1):105. PubMed ID: 35897078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of five partial volume correction methods for Tau and Amyloid PET imaging with [
    Shidahara M; Thomas BA; Okamura N; Ibaraki M; Matsubara K; Oyama S; Ishikawa Y; Watanuki S; Iwata R; Furumoto S; Tashiro M; Yanai K; Gonda K; Watabe H
    Ann Nucl Med; 2017 Aug; 31(7):563-569. PubMed ID: 28639126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PET.
    Gonzalez-Escamilla G; Lange C; Teipel S; Buchert R; Grothe MJ;
    Neuroimage; 2017 Feb; 147():669-677. PubMed ID: 28039094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial volume correction for PET quantification and its impact on brain network in Alzheimer's disease.
    Yang J; Hu C; Guo N; Dutta J; Vaina LM; Johnson KA; Sepulcre J; Fakhri GE; Li Q
    Sci Rep; 2017 Oct; 7(1):13035. PubMed ID: 29026139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Analysis of Brain [
    Alongi P; Laudicella R; Panasiti F; Stefano A; Comelli A; Giaccone P; Arnone A; Minutoli F; Quartuccio N; Cupidi C; Arnone G; Piccoli T; Grimaldi LME; Baldari S; Russo G
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35453981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose CT for the spatial normalization of PET images: A validation procedure for amyloid-PET semi-quantification.
    Presotto L; Iaccarino L; Sala A; Vanoli EG; Muscio C; Nigri A; Bruzzone MG; Tagliavini F; Gianolli L; Perani D; Bettinardi V
    Neuroimage Clin; 2018; 20():153-160. PubMed ID: 30094164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric imaging hippocampal neurodegeneration and functional connectivity with simultaneous PET/MRI in Alzheimer's disease.
    Yan S; Zheng C; Cui B; Qi Z; Zhao Z; An Y; Qiao L; Han Y; Zhou Y; Lu J
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2440-2452. PubMed ID: 32157432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.